Clinical Trial Update: 2-5 Intermittent Caloric Restriction in HIV [NA]

View source ↗

Summary

Clinical trial of intermittent caloric restriction in people with HIV and metabolic syndrome was terminated; results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus
• Metabolic Syndrome

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Human Immunodeficiency Virus, Metabolic Syndrome | NA | Status: TERMINATED | Results posted: 2022-10-13